AAAAAA

   
Results: 1-15 |
Results: 15
ELDERLY DONORS IN RENAL-TRANSPLANTATION - A WORTHWHILE VENTURE
Authors: LEWIS DM GORRIE M BINGHAM C NICHOLS AJ BEAMAN M RIAD HN
Citation: Dm. Lewis et al., ELDERLY DONORS IN RENAL-TRANSPLANTATION - A WORTHWHILE VENTURE, Transplantation proceedings, 30(5), 1998, pp. 2279-2279
BINDING OF [H-3]-SK-AND-F-107260 AND [H-3]-SB-214857 TO PURIFIED INTEGRIN ALPHA(IIB)BETA-3 - EVIDENCE FOR A COMMON BINDING-SITE FOR CYCLIC ARGINYL-GLYCINYL-ASPARTIC ACID PEPTIDES AND NONPEPTIDES
Authors: WONG A HWANG SM JOHANSON K SAMANEN J BENNETT D LANDVATTER SW CHEN WT HEYS JR ALI FE KU TW BONDINELL W NICHOLS AJ POWERS DA STADEL JM
Citation: A. Wong et al., BINDING OF [H-3]-SK-AND-F-107260 AND [H-3]-SB-214857 TO PURIFIED INTEGRIN ALPHA(IIB)BETA-3 - EVIDENCE FOR A COMMON BINDING-SITE FOR CYCLIC ARGINYL-GLYCINYL-ASPARTIC ACID PEPTIDES AND NONPEPTIDES, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 228-235
THE USE OF RABBIT INTESTINAL PERMEABILITY AS AN IN-VITRO ASSAY IN THESEARCH FOR ORALLY-ACTIVE GPIIB IIIA ANTAGONISTS/
Authors: SAMANEN JM LEE CP SMITH PL BONDINELL WE CALVO RR JAKAS DR NEWLANDER KA PARKER M UZINSKAS I YELLIN TO NICHOLS AJ
Citation: Jm. Samanen et al., THE USE OF RABBIT INTESTINAL PERMEABILITY AS AN IN-VITRO ASSAY IN THESEARCH FOR ORALLY-ACTIVE GPIIB IIIA ANTAGONISTS/, Advanced drug delivery reviews, 23(1-3), 1997, pp. 133-142
NOVEL MURINE MONOCLONAL ANTI-FACTOR IX IXA (BC2) IS A POTENT ANTICOAGULANT WITH SELF-LIMITING INHIBITION OF HEMOSTASIS/
Authors: FEUERSTEIN GZ NICHOLS AJ CHURCH WR PATEL A BLACKBURN MN VALOCIK RE KOSTER PF
Citation: Gz. Feuerstein et al., NOVEL MURINE MONOCLONAL ANTI-FACTOR IX IXA (BC2) IS A POTENT ANTICOAGULANT WITH SELF-LIMITING INHIBITION OF HEMOSTASIS/, Circulation, 96(8), 1997, pp. 221-221
STRUCTURE-ACTIVITY-RELATIONSHIPS IN 3-OXO-1,4-BENZODIAZEPINE-2-ACETICACID GPIIB IIIA ANTAGONISTS - THE 2-BENZAZEPINE SERIES/
Authors: MILLER WH ALI FE BONDINELL WE CALLAHAN JF CALVO RR EGGLESTON DS HALTIWANGER RC HUFFMAN WF HWANG SM JAKAS DR KEENAN RM KOSTER PF KU TW KWON C NEWLANDER KA NICHOLS AJ PARKER MF SAMANEN JM SOUTHALL LS TAKATA DT UZINSKAS IN VALOCIK RE VASKOMOSER JA WONG AS YELLIN TO YUAN CCK
Citation: Wh. Miller et al., STRUCTURE-ACTIVITY-RELATIONSHIPS IN 3-OXO-1,4-BENZODIAZEPINE-2-ACETICACID GPIIB IIIA ANTAGONISTS - THE 2-BENZAZEPINE SERIES/, Bioorganic & medicinal chemistry letters, 6(21), 1996, pp. 2481-2486
ANTIFIBRILLATORY EFFECTS OF BRL-32872 IN ANESTHETIZED YUCATAN MINIPIGS WITH REGIONAL MYOCARDIAL-ISCHEMIA
Authors: GOUT B NICHOLS AJ FEUERSTEIN GZ BRIL A
Citation: B. Gout et al., ANTIFIBRILLATORY EFFECTS OF BRL-32872 IN ANESTHETIZED YUCATAN MINIPIGS WITH REGIONAL MYOCARDIAL-ISCHEMIA, Journal of cardiovascular pharmacology, 26(4), 1995, pp. 636-644
CARDIOPROTECTION AND THROMBOLYSIS BY ANISTREPLASE IN ANESTHETIZED DOGS
Authors: FEUERSTEIN GZ NICHOLS AJ VALOCIK RE GAGNON T SELLARS TS FEARS RC FERRES H RUFFOLO RR
Citation: Gz. Feuerstein et al., CARDIOPROTECTION AND THROMBOLYSIS BY ANISTREPLASE IN ANESTHETIZED DOGS, Journal of cardiovascular pharmacology, 25(4), 1995, pp. 625-633
POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS WHICH PRESENT AN ALTERNATIVE PHARMACOPHORE
Authors: KU TW MILLER WH BONDINELL WE ERHARD KF KEENAN RM NICHOLS AJ PEISHOFF CE SAMANEN JM WONG AS HUFFMAN WF
Citation: Tw. Ku et al., POTENT NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS WHICH PRESENT AN ALTERNATIVE PHARMACOPHORE, Journal of medicinal chemistry, 38(1), 1995, pp. 9-12
IDENTIFYING SALIENT BELIEFS ABOUT LEISURE ACTIVITIES - FREQUENCY OF ELICITATION VERSUS RESPONSE LATENCY
Authors: AJZEN I NICHOLS AJ DRIVER BL
Citation: I. Ajzen et al., IDENTIFYING SALIENT BELIEFS ABOUT LEISURE ACTIVITIES - FREQUENCY OF ELICITATION VERSUS RESPONSE LATENCY, Journal of applied social psychology, 25(16), 1995, pp. 1391-1410
THE IN-VITRO PHARMACOLOGICAL PROFILE OF SK-AND-F-106760, A NOVEL GPIIB IIIA ANTAGONIST/
Authors: NICHOLS AJ VASKO JA VALOCIK RE KOPACIEWICZ LJ STORER BL ALI FE ROMOFF T CALVO R SAMANEN JM
Citation: Aj. Nichols et al., THE IN-VITRO PHARMACOLOGICAL PROFILE OF SK-AND-F-106760, A NOVEL GPIIB IIIA ANTAGONIST/, Thrombosis research, 75(2), 1994, pp. 143-156
THE IN-VIVO PHARMACOLOGICAL PROFILE OF THE NOVEL GLYCOPROTEIN-IIB IIIA ANTAGONIST, SK-AND-F-106760/
Authors: NICHOLS AJ VASKO JA KOSTER PF VALOCIK RE RHODES GR MILLERSTEIN C BOPPANA V SAMANEN JM
Citation: Aj. Nichols et al., THE IN-VIVO PHARMACOLOGICAL PROFILE OF THE NOVEL GLYCOPROTEIN-IIB IIIA ANTAGONIST, SK-AND-F-106760/, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 614-621
CONFORMATIONALLY CONSTRAINED PEPTIDES AND SEMIPEPTIDES DERIVED FROM RGD AS POTENT INHIBITORS OF THE PLATELET FIBRINOGEN RECEPTOR AND PLATELET-AGGREGATION
Authors: ALI FE BENNETT DB CALVO RR ELLIOTT JD HWANG SM KU TW LAGO MA NICHOLS AJ ROMOFF TT SHAH DH VASKO JA WONG AS YELLIN TO YUAN CK SAMANEN JM
Citation: Fe. Ali et al., CONFORMATIONALLY CONSTRAINED PEPTIDES AND SEMIPEPTIDES DERIVED FROM RGD AS POTENT INHIBITORS OF THE PLATELET FIBRINOGEN RECEPTOR AND PLATELET-AGGREGATION, Journal of medicinal chemistry, 37(6), 1994, pp. 769-780
PHARMACOLOGICAL AND THERAPEUTIC APPLICATIONS OF ALPHA-2-ADRENOCEPTOR SUBTYPES
Authors: RUFFOLO RR NICHOLS AJ STADEL JM HIEBLE JP
Citation: Rr. Ruffolo et al., PHARMACOLOGICAL AND THERAPEUTIC APPLICATIONS OF ALPHA-2-ADRENOCEPTOR SUBTYPES, Annual review of pharmacology and toxicology, 33, 1993, pp. 243-279
A CHRONIC ACCESS PORT MODEL FOR DIRECT DELIVERY OF DRUGS INTO THE INTESTINE OF CONSCIOUS DOGS
Authors: MEUNIER LD KISSINGER JT MARCELLO J NICHOLS AJ SMITH PL
Citation: Ld. Meunier et al., A CHRONIC ACCESS PORT MODEL FOR DIRECT DELIVERY OF DRUGS INTO THE INTESTINE OF CONSCIOUS DOGS, Laboratory animal science, 43(5), 1993, pp. 466-470
CARDIOVASCULAR ACTIONS OF A NEW SELECTIVE POSTJUNCTIONAL ALPHA-ADRENOCEPTOR ANTAGONIST, SK-AND-F-104856, IN NORMOTENSIVE AND HYPERTENSIVE DOGS
Authors: HIEBLE JP NICHOLS AJ FREDRICKSON TA DEPALMA PD RUFFOLO RR BROOKS DP
Citation: Jp. Hieble et al., CARDIOVASCULAR ACTIONS OF A NEW SELECTIVE POSTJUNCTIONAL ALPHA-ADRENOCEPTOR ANTAGONIST, SK-AND-F-104856, IN NORMOTENSIVE AND HYPERTENSIVE DOGS, British Journal of Pharmacology, 105(4), 1992, pp. 992-996
Risultati: 1-15 |